Midazolam administration reverses thermal hyperalgesia and prevents γ-aminobutyric acid transporter loss in a rodent model of neuropathic pain

Anesthesia and Analgesia

Volumn 106, Issue 4, 2008, Pages 1296-1302

  Shih, Andre ^a   Miletic, Vjekoslav ^b   Miletic, Gordana ^b   Smith, Lesley J ^c  

^a University of Florida   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; FLUMAZENIL; MIDAZOLAM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; HYPERALGESIA; MALE; MONOTHERAPY; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD DORSAL HORN;

EID: 41349084430     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318164f1e9     Document Type: Article

References (36)

1. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron 2006;52:77-92
2. Harden RN. Chronic neuropathic pain; mechanisms, diagnosis, and treatment. Neurologist 2005;11:111-22
3. Wallace MS. Pharmacologic treatment of neuropathic pain. Curr Pain Headache Rep 2001;5:138-50
4. Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003;102:1-8
5. Dickenson AH, Chapman V, Green GM. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol 1997;28:633-8
6. Eaton MJ. Emerging cell and molecular strategies for the study and treatment of painful peripheral neuropathies. J Peripher Nerv Syst 2000;5:59-74
7. Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain 2002;6(suppl A):61-8
8. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989;37:111-23
9. Todd AJ, McKenzie J. GABA-immunoreactive neurons in the dorsal horn of the rat spinal cord. Neuroscience 1989;31:799-806
10. Malan TP, Mata HP, Porreca F. Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain. Anesthesiology 2002;96:1161-7
11. Kaneko M, Hammond DL. Role of spinal gamma-aminobutyric acid A receptors in formalin-induced nociception in the rat. J Pharmacol Exp Ther 1997;282:928-38
12. Soudijn W, van Wijngaarden I. The GABA transporter and its inhibitors. Curr Med Chem 2000;7:1063-79
13. Conti F, Minelli A, Melone M. GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications. Brain Res Rev 2004;45:196-212
14. Miletic G, Draganic P, Pankratz MT, Miletic V. Muscimol prevents long-lasting potentiation of dorsal horn field potentials in rats with chronic constriction injury exhibiting decreased levels of the GABA transporter GAT-1. Pain 2003;105:347-53
15. Reves JG, Glass PSA, Lubarsky DA, McEvoy MD. Intravenous nonopioid anesthetics. In: RD Miller, ed. Miller's anesthesia. 6th ed. Philadelphia: Elsevier Churchill Livingstone, 2005:334-44
16. Kontinen VK, Dickenson AH. Effects of midazolam in the spinal nerve ligation model of neuropathic pain in rats. Pain 2000;85:425-31
17. Lim J, Lim G, Sung B, Wang S, Mao J. Intrathecal midazolam regulates spinal AMPA receptor expression and function after nerve injury in rats. Brain Res 2006;1123:80-8
18. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10
19. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107
20. Smith LJ, Shih A, Miletic G, Miletic V. Continual systemic infusion of lidocaine provides analgesia in an animal model of neuropathic pain. Pain 2002;97:267-73
21. McKenzie CA, McKinnon W, Naughton DP, Treacher D, Davies G, Phillips GJ, Hilton PJ. Differentiating midazolam over-sedation from neurological damage in the intensive care unit. Critical Care 2005;9:R32-R36
22. Edwards M, Serrao JM, Gent JP, Goodchild CS. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology 1990;73:273-7
23. Goodchild CS, Serrao JM. Intrathecal midazolam in the rat: evidence for spinally-mediated analgesia. Br J Anaesth 1987;59:1563-70
24. Kohno T, Wakai A, Ataka T, Ikoma M, Yamakura T, Baba H. Actions of midazolam on excitatory transmission in dorsal horn neurons of adult rat spinal cord. Anesthesiology 2006;104:338-43
25. Kyles AE, Waterman AE, Livingston A. Antinociceptive activity of midazolam in sheep. J Vet Pharmacol Therap 1995;18:54-60
26. Clavier N, Lombard MC, Besson JM. Benzodiazepines and pain: effects of midazolam on the activities of nociceptive non-specific dorsal horn neurons in the rat spinal cord. Pain 1992;48:61-71
27. Tatsuo MAKF, Salgado JV, Yokoro CM, Duarte IDG, Francishci JN. Midazolam-induced hyperalgesia in rats: modulation via GABA-A receptors at supraspinal level. Eur J Pharmacol 1999;370:9-15
28. Serrao JM, Marks RL, Morley SJ, Goodchild CS. Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study. Pain 1992;48:5-12
29. Schoeffler P, Auroy P, Bazin JE, Taxi J, Woda A. Subarachnoid midazolam: histologic study in rats and report of its effect on chronic pain in humans. Reg Anesth 1991;6:329-32
30. Hugel H, Ellershaw JE, Dickman A. Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic pain. J Pain Symptom Manag 2003;26:1073-4
31. Wajima Z, Shitara T, Inoue T, Ogawa R. Severe lightning pain after subarachnoid block in a patient with neuropathic pain of central origin: which drug is best to treat the pain? Clin J Pain 2000;16:265-9
32. Yamamoto T, Yaksh TL. Effects of intrathecal strychnine and bicuculline on nerve compression-induced thermal hyperalgesia and selective antagonism by MK-801. Pain 1993;54:79-84
33. Sivilotti L, Woolf CJ. The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J Neurophysiol 1994;72:169-79
34. Hao JX, Xu XJ, Wiesenfeld-Hallin Z. Intrathecal gamma-aminobutyric acid B (GABAB) receptor antagonist CGP 35348 induces hypersensitivity to mechanical stimuli in the rat. Neurosci Lett 1994;182:299-302
35. Teuber L, Watjens F, Jensen LH. Ligands for the benzodiazepine binding site-a survey. Curr Pharm Des 1999;5:317-43
36. Miletic G, Miletic V. Neuropathic pain elicited by loose ligation of the sciatic nerve is associated with early TrkB receptor-dependent decreases in KCC2 protein levels in the ipsilateral spinal dorsal horn. Soc Neurosci Abstr 2007;Prog. No. 286.6